Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000781 | chromosome, telomeric region | 3 | 2 |
GO:0005634 | nucleus | 5 | 6 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005662 | DNA replication factor A complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0035861 | site of double-strand break | 3 | 2 |
GO:0043226 | organelle | 2 | 6 |
GO:0043227 | membrane-bounded organelle | 3 | 6 |
GO:0043229 | intracellular organelle | 3 | 6 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 6 |
GO:0090734 | site of DNA damage | 2 | 2 |
GO:0098687 | chromosomal region | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
Related structures:
AlphaFold database: Q4QFF3
Term | Name | Level | Count |
---|---|---|---|
GO:0000724 | double-strand break repair via homologous recombination | 7 | 2 |
GO:0000725 | recombinational repair | 6 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 6 |
GO:0006259 | DNA metabolic process | 4 | 6 |
GO:0006260 | DNA replication | 5 | 6 |
GO:0006281 | DNA repair | 5 | 6 |
GO:0006289 | nucleotide-excision repair | 6 | 2 |
GO:0006302 | double-strand break repair | 6 | 2 |
GO:0006310 | DNA recombination | 5 | 6 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 6 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0006950 | response to stress | 2 | 6 |
GO:0006974 | DNA damage response | 4 | 6 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0009987 | cellular process | 1 | 6 |
GO:0033554 | cellular response to stress | 3 | 6 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 6 |
GO:0043170 | macromolecule metabolic process | 3 | 6 |
GO:0044237 | cellular metabolic process | 2 | 6 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 6 |
GO:0046483 | heterocycle metabolic process | 3 | 6 |
GO:0050896 | response to stimulus | 1 | 6 |
GO:0051716 | cellular response to stimulus | 2 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:0090304 | nucleic acid metabolic process | 4 | 6 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003677 | DNA binding | 4 | 6 |
GO:0003697 | single-stranded DNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 140 | 144 | PF00656 | 0.417 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.556 |
CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.296 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.556 |
CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.398 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.560 |
DOC_CKS1_1 | 129 | 134 | PF01111 | 0.461 |
DOC_MAPK_DCC_7 | 27 | 37 | PF00069 | 0.440 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.581 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.296 |
DOC_WW_Pin1_4 | 128 | 133 | PF00397 | 0.461 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.577 |
LIG_14-3-3_CanoR_1 | 226 | 234 | PF00244 | 0.296 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.467 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.467 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.467 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.296 |
LIG_FHA_1 | 93 | 99 | PF00498 | 0.467 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.296 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.386 |
LIG_LIR_LC3C_4 | 95 | 100 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.452 |
LIG_NRBOX | 196 | 202 | PF00104 | 0.296 |
LIG_PDZ_Class_2 | 252 | 257 | PF00595 | 0.419 |
LIG_SH2_GRB2like | 70 | 73 | PF00017 | 0.479 |
LIG_SH2_NCK_1 | 70 | 74 | PF00017 | 0.457 |
LIG_SH2_SRC | 70 | 73 | PF00017 | 0.479 |
LIG_SH3_1 | 28 | 34 | PF00018 | 0.458 |
LIG_SH3_3 | 28 | 34 | PF00018 | 0.458 |
LIG_SUMO_SIM_par_1 | 111 | 117 | PF11976 | 0.424 |
LIG_SUMO_SIM_par_1 | 49 | 54 | PF11976 | 0.376 |
LIG_WRC_WIRS_1 | 201 | 206 | PF05994 | 0.296 |
MOD_CK1_1 | 171 | 177 | PF00069 | 0.339 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.296 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.267 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.300 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.303 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.337 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.251 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.306 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.597 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.491 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.531 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.293 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.296 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.597 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.296 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.296 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.194 |
MOD_PIKK_1 | 159 | 165 | PF00454 | 0.296 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.367 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.467 |
MOD_PKA_2 | 159 | 165 | PF00069 | 0.296 |
MOD_PKA_2 | 89 | 95 | PF00069 | 0.467 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.467 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.296 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.278 |
MOD_ProDKin_1 | 128 | 134 | PF00069 | 0.461 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.577 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.391 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.586 |
TRG_Pf-PMV_PEXEL_1 | 239 | 244 | PF00026 | 0.296 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2B8 | Leptomonas seymouri | 89% | 100% |
A0A1X0NTN7 | Trypanosomatidae | 62% | 100% |
A0A3Q8IDB6 | Leishmania donovani | 98% | 100% |
A0A3S5IRR4 | Trypanosoma rangeli | 63% | 96% |
A1L2H9 | Xenopus laevis | 26% | 94% |
A4H800 | Leishmania braziliensis | 92% | 100% |
A4HWC8 | Leishmania infantum | 98% | 100% |
E9AQ28 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
P15927 | Homo sapiens | 24% | 95% |
Q13156 | Homo sapiens | 24% | 98% |
Q23697 | Crithidia fasciculata | 85% | 100% |
Q5RC43 | Pongo abelii | 25% | 95% |
Q62193 | Mus musculus | 24% | 95% |
Q63528 | Rattus norvegicus | 24% | 95% |
Q6DFS2 | Xenopus tropicalis | 25% | 93% |
Q6IP18 | Xenopus laevis | 27% | 93% |
Q6K9U2 | Oryza sativa subsp. japonica | 25% | 92% |
Q8LFJ8 | Arabidopsis thaliana | 22% | 92% |
Q92373 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 30% | 92% |